-
Clinical Pharmacology: Advances and Applications
-
About Dovepress
Open access peer-reviewed scientific and medical journals.
-
Open Access
Dove Medical Press is now a member of the Open Access Initiative
-
An Author's Guide
A guide to help authors get their paper published.
-
Advocacy
Support Open Access and Dove Press
-
Reprints
Promotional Article Monitoring - further details
-
Favored Author Program
Real benefits for authors, including fast-track processing of papers.
Analgesic efficacy of oral gabapentin added to standard epidural corticosteroids in patients with failed back surgery
Original Research
(1959) Views (531) Full article downloads
Authors: Beyazit Zencirci
Published Date September 2010
Volume 2010:2 Pages 207 - 211
DOI: http://dx.doi.org/10.2147/CPAA.S12126
Beyazit Zencirci
Department of Anesthesiology and Reanimation, Medical Faculty of Sutcu Imam University, Kahramanmaras, Turkey
Objective: Failed back surgery syndrome is characterized by the presence of intractable pain and varying degrees of functional incapacity after lumbar spine surgery. Because the mechanisms that cause pain are variable, treatment of this syndrome is quite difficult, and one of the most common methods that is used for treatment nowadays is epidural injection. This research evaluates the analgesic efficacy of addition of oral gabapentin treatment to epidural corticosteroid application in patients with failed back surgery syndromes.
Methods: Forty-two patients, including 23 females and 19 males, with failed back surgery syndrome who had been previously operated on at least twice due to lumbar disc herniation were randomly divided into two groups. Following epidural application of a single dose of methylprednisolone in the first group of patients (Group K), an oral medical treatment containing naproxen sodium, tizanidine, and vitamin B and C complex, was devised to be applied for one month. For the second group, oral gabapentin was added to the same treatment regime (Group G). Pain levels were evaluated by a visual analog scale for straight leg raise before, during, and after treatment, as well as in the first and third months.
Results: There was no demographically significant difference between the patients (P > 0.05). After the beginning of treatment, it was observed that the pain level in Group G patients regressed earlier and that it progressed at a significantly lower level (both in the first and third month controls).
Conclusion: It was concluded that addition of oral gabapentin to epidural corticosteroid application in patients with failed back surgery syndromes was effective in ameliorating pain at an early stage without significant side effects.
Keywords: failed back surgery syndrome, epidural corticosteroid, gabapentin
Other articles by Dr Beyazit Zencirci
Marfan syndrome with acute abdomen: a case report
Postdural puncture headache and pregabalin
Safe spinal anesthesia in a woman with chronic renal failure and placenta previa
Sertraline-induced pseudocholinesterase enzyme deficiency
Readers of this article also read:
"Globalized public health.” A transdisciplinary comprehensive framework for analyzing contemporary globalization’s influences on the field of public health
Safe spinal anesthesia in a woman with chronic renal failure and placenta previa
Hepatitis C virus infection and risk of cancer: a population-based cohort study
Testosterone replacement in male hypogonadism
A comparative study of DNA damage in patients suffering from diabetes and thyroid dysfunction and complications
Sertraline-induced pseudocholinesterase enzyme deficiency
Using systematically observed clinical encounters (SOCEs) to assess medical students’ skills in clinical settings
Neuronal potassium channel openers in the management of epilepsy: role and potential of retigabine
Cardiovascular risk during hormonal treatment in patients with prostate cancer
- Testimonials
"... I was impressed at the rapidity of publication from submission to final acceptance." Dr Edwin Thrower, PhD, Yale University
- The benefits and risks of testosterone replacement therapy: a review
- Tenofovir-associated bone density loss
- Drug design with Cdc7 kinase: a potential novel cancer therapy target
- Development of mucosal adjuvants for intranasal vaccine for H5N1 influenza viruses




